{"id":"https://openalex.org/W1978985435","doi":"https://doi.org/10.1002/med.1021","title":"Cyclin\u2010dependent kinase inhibitors for treating cancer","display_name":"Cyclin\u2010dependent kinase inhibitors for treating cancer","alternate_titles":[],"publication_year":2001,"publication_date":"2001-10-05","ids":{"openalex":"https://openalex.org/W1978985435","doi":"https://doi.org/10.1002/med.1021","mag":"1978985435","pmid":"https://pubmed.ncbi.nlm.nih.gov/11607930"},"language":"en","primary_location":{"id":"doi:10.1002/med.1021","doi":"https://doi.org/10.1002/med.1021","is_oa":false,"landing_page_url":"https://doi.org/10.1002/med.1021","pdf_url":null,"source":{"id":"https://openalex.org/S22382660","display_name":"Medicinal Research Reviews","issn_l":"0198-6325","issn":["0198-6325","1098-1128"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Medicinal Research Reviews","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W1978985435"],"child_works_count":0,"type":"review","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5076199303","display_name":"Peter L. Toogood","orcid":"https://orcid.org/0000-0002-8938-6960","observed_orcids":["https://orcid.org/0000-0002-8938-6960"]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Peter L. Toogood","raw_affiliation_strings":["Department of Medicinal Chemistry, Pfizer Global Research & Development, Ann Arbor Laboratories, Ann Arbor, Michigan 48105, USA. Peter.toogood2@pfizer.com","Department of Medicinal Chemistry, Pfizer Global Research & Development, Ann Arbor Laboratories, Ann Arbor, Michigan 48105, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicinal Chemistry, Pfizer Global Research & Development, Ann Arbor Laboratories, Ann Arbor, Michigan 48105, USA. Peter.toogood2@pfizer.com","institution_ids":["https://openalex.org/I180857899"]},{"raw_affiliation_string":"Department of Medicinal Chemistry, Pfizer Global Research & Development, Ann Arbor Laboratories, Ann Arbor, Michigan 48105, USA","institution_ids":["https://openalex.org/I180857899"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5076199303"],"corresponding_institution_ids":["https://openalex.org/I180857899"],"apc_list":{"value":4980,"currency":"USD","value_usd":4980},"apc_paid":null,"fwci":1.3445,"has_fulltext":false,"cited_by_count":101,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.80621762,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":98},"biblio":{"volume":"21","issue":"6","first_page":"487","last_page":"498"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10583","display_name":"Cancer-related Molecular Pathways","score":0.8574000000953674,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10583","display_name":"Cancer-related Molecular Pathways","score":0.8574000000953674,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10274","display_name":"Heterocyclic Compound Synthesis and Bioactivity","score":0.10660000145435333,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10952","display_name":"PI3K/AKT/mTOR signaling in cancer","score":0.006800000090152025,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cyclin-dependent-kinase-inhibitors","display_name":"cyclin-dependent kinase inhibitors","score":0.9869999885559082},{"id":"https://openalex.org/keywords/pyrido-2-3-d-pyrimidines","display_name":"pyrido[2,3-d]pyrimidines","score":0.7950000166893005},{"id":"https://openalex.org/keywords/cdk2","display_name":"CDK2","score":0.6769999861717224},{"id":"https://openalex.org/keywords/structure-activity-relationship","display_name":"structure-activity relationship","score":0.8259999752044678},{"id":"https://openalex.org/keywords/small-molecule-kinase-inhibitors","display_name":"small-molecule kinase inhibitors","score":0.6570000052452087},{"id":"https://openalex.org/keywords/cell-cycle-regulation","display_name":"cell cycle regulation","score":0.5870000123977661},{"id":"https://openalex.org/keywords/g1-cell-cycle-arrest","display_name":"G1 cell cycle arrest","score":0.718999981880188},{"id":"https://openalex.org/keywords/retinoblastoma-protein","display_name":"retinoblastoma protein","score":0.878000020980835},{"id":"https://openalex.org/keywords/cancer-therapy","display_name":"cancer therapy","score":0.5370000004768372}],"concepts":[{"id":"https://openalex.org/C124320809","wikidata":"https://www.wikidata.org/wiki/Q46292","display_name":"Cyclin-dependent kinase","level":4,"score":0.9141018986701965},{"id":"https://openalex.org/C184235292","wikidata":"https://www.wikidata.org/wiki/Q421851","display_name":"Kinase","level":2,"score":0.6187885403633118},{"id":"https://openalex.org/C29537977","wikidata":"https://www.wikidata.org/wiki/Q188941","display_name":"Cell cycle","level":3,"score":0.5250511169433594},{"id":"https://openalex.org/C175738201","wikidata":"https://www.wikidata.org/wiki/Q5198255","display_name":"Cyclin-dependent kinase complex","level":5,"score":0.5099183320999146},{"id":"https://openalex.org/C82495950","wikidata":"https://www.wikidata.org/wiki/Q14911732","display_name":"Cyclin-dependent kinase 2","level":4,"score":0.5092819929122925},{"id":"https://openalex.org/C11882975","wikidata":"https://www.wikidata.org/wiki/Q24781041","display_name":"Cyclin D","level":5,"score":0.5081360340118408},{"id":"https://openalex.org/C16438837","wikidata":"https://www.wikidata.org/wiki/Q5198260","display_name":"Cyclin A","level":5,"score":0.4882550537586212},{"id":"https://openalex.org/C120089663","wikidata":"https://www.wikidata.org/wiki/Q59250999","display_name":"Cyclin","level":4,"score":0.4630264341831207},{"id":"https://openalex.org/C51853150","wikidata":"https://www.wikidata.org/wiki/Q14911754","display_name":"Cyclin-dependent kinase 4","level":5,"score":0.45525914430618286},{"id":"https://openalex.org/C2779343474","wikidata":"https://www.wikidata.org/wiki/Q3109175","display_name":"Context (archaeology)","level":2,"score":0.44877541065216064},{"id":"https://openalex.org/C2778298596","wikidata":"https://www.wikidata.org/wiki/Q17143494","display_name":"CDK inhibitor","level":5,"score":0.4316532015800476},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.4190920293331146},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.4157712459564209},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.3958398699760437},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.3854869306087494},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.3572521209716797},{"id":"https://openalex.org/C1491633281","wikidata":"https://www.wikidata.org/wiki/Q7868","display_name":"Cell","level":2,"score":0.20330718159675598},{"id":"https://openalex.org/C97029542","wikidata":"https://www.wikidata.org/wiki/Q281417","display_name":"Protein kinase A","level":3,"score":0.1662708818912506},{"id":"https://openalex.org/C151730666","wikidata":"https://www.wikidata.org/wiki/Q7205","display_name":"Paleontology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D002453","descriptor_name":"Cell Cycle","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D004791","descriptor_name":"Enzyme Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D004791","descriptor_name":"Enzyme Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D004791","descriptor_name":"Enzyme Inhibitors","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D013329","descriptor_name":"Structure-Activity Relationship","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013379","descriptor_name":"Substrate Specificity","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018844","descriptor_name":"Cyclin-Dependent Kinases","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D018844","descriptor_name":"Cyclin-Dependent Kinases","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1002/med.1021","doi":"https://doi.org/10.1002/med.1021","is_oa":false,"landing_page_url":"https://doi.org/10.1002/med.1021","pdf_url":null,"source":{"id":"https://openalex.org/S22382660","display_name":"Medicinal Research Reviews","issn_l":"0198-6325","issn":["0198-6325","1098-1128"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Medicinal Research Reviews","raw_type":"journal-article"},{"id":"pmid:11607930","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/11607930","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Medicinal research reviews","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.8371999859809875,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":40,"referenced_works":["https://openalex.org/W97735725","https://openalex.org/W1576328952","https://openalex.org/W1599861993","https://openalex.org/W1728706259","https://openalex.org/W1851389060","https://openalex.org/W1911118961","https://openalex.org/W1919908042","https://openalex.org/W1968789750","https://openalex.org/W1969355167","https://openalex.org/W1971140803","https://openalex.org/W1985075123","https://openalex.org/W1999319877","https://openalex.org/W2007255413","https://openalex.org/W2014462533","https://openalex.org/W2015066175","https://openalex.org/W2015902966","https://openalex.org/W2018537155","https://openalex.org/W2025215722","https://openalex.org/W2029080338","https://openalex.org/W2040736465","https://openalex.org/W2043761487","https://openalex.org/W2045753932","https://openalex.org/W2072906848","https://openalex.org/W2080443370","https://openalex.org/W2089528428","https://openalex.org/W2097981550","https://openalex.org/W2098517912","https://openalex.org/W2104373322","https://openalex.org/W2105768236","https://openalex.org/W2111420633","https://openalex.org/W2120607327","https://openalex.org/W2121619780","https://openalex.org/W2135129680","https://openalex.org/W2146428402","https://openalex.org/W2153640566","https://openalex.org/W2169927110","https://openalex.org/W2464434376","https://openalex.org/W2949985550","https://openalex.org/W3153391969","https://openalex.org/W6602939890"],"related_works":["https://openalex.org/W1993054739","https://openalex.org/W1985389450","https://openalex.org/W1985075123","https://openalex.org/W2079096219","https://openalex.org/W2155230284","https://openalex.org/W2120350411","https://openalex.org/W2087287369","https://openalex.org/W2166317851","https://openalex.org/W2040609223","https://openalex.org/W2405762190"],"abstract_inverted_index":{"Cyclin":[0],"dependent":[1],"kinases":[2,17],"(Cdks)":[3],"are":[4,18,63,96,109],"essential":[5],"enzymes":[6],"for":[7,81,87,98],"the":[8,101,112,122,138],"control":[9],"of":[10,15,28,35,50,55,114,140],"cell":[11,143,149],"cycle":[12],"progression.":[13],"Inhibitors":[14],"cyclin-dependent":[16],"anticipated":[19],"to":[20,47,72,78,135,152],"possess":[21],"therapeutic":[22],"utility":[23],"against":[24,68],"a":[25,48,53,115,146,154],"wide":[26],"variety":[27],"proliferative":[29],"diseases,":[30],"especially":[31],"cancer.":[32],"The":[33],"field":[34],"published":[36],"small":[37],"molecule":[38],"Cdk":[39,57],"inhibitors":[40],"is":[41,84,119,133],"briefly":[42],"reviewed":[43],"here":[44],"as":[45],"background":[46],"summary":[49],"work":[51],"on":[52,121],"class":[54,62],"pyrido[2,3-d]pyrimidine":[56],"inhibitors.":[58],"Compounds":[59],"from":[60],"this":[61,90],"described":[64],"that":[65,118],"display":[66],"potency":[67],"cyclin":[69,82,128,160],"D/Cdk4":[70,83,129,161],"up":[71],"IC(50)":[73],"=":[74],"0.004":[75],"microM.":[76],"Good":[77],"moderate":[79],"selectivity":[80],"also":[85],"reported":[86],"compounds":[88],"in":[89,111,163],"structural":[91],"class.":[92],"Structure-activity":[93],"relationship":[94],"data":[95,108],"presented":[97],"substitution":[99],"at":[100],"C2":[102],"and":[103,106,151],"N8":[104],"positions":[105],"these":[107],"interpreted":[110],"context":[113],"binding":[116],"model":[117],"based":[120],"Cdk2":[123],"crystal":[124],"structure.":[125],"A":[126],"representative":[127],"inhibitor":[130],"(compound":[131],"56)":[132],"demonstrated":[134],"selectively":[136],"inhibit":[137],"proliferation":[139],"an":[141],"Rb(+)":[142],"line":[144,150],"vs.":[145],"matched":[147],"Rb(-)":[148],"produce":[153],"distinct":[155],"G(1)":[156],"block":[157],"consistent":[158],"with":[159],"inhibition":[162],"cells.":[164]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W1978985435","counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":3},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":3},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":2},{"year":2014,"cited_by_count":6},{"year":2013,"cited_by_count":2},{"year":2012,"cited_by_count":3}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
